Early prostate cancer should choose the radioactive particle treatment first

Early prostate cancer should choose the radioactive particle treatment first
Early prostate cancer should choose the radioactive particle treatment first
It is reported ' Reporter and king build special correspondent Zhang XiuHua of the shadow) Organize room treat tumour at the academic conference at short range in 2010 international radioactive particle that September 3 hold, the experts point out, the radioactive particle treatment relies on the high cure rate, low the advantage of damaging, repeatable etc. can well match in excellence or beauty with the surgery, and the damage to the patient is smaller, so become the early prostate cancer patient's first-selected therapeutic method. Radioactive particle until Ultrasonography B and CT guide in treatment, through the special syringe, put radioactive particle 125I into it within tumour, kill tumour cells through the radioactivity of 125I. Radioactive the intersection of particle and application of treatment make survival rate raise get 95% early 5 year in patient such as cancer such as prostate, and survival rate is only 87% in 5 treating the patient in previous surgery. The third hospital radiotherapy in Peking University finished prostate cancer to treat with this technology for the first time in 2001. Nearly 700 hospitals launch this technology in the whole country at present, apply to the treatment of entity's tumour of every position of whole body extensively, for instance lung cancer, hepatocarcinoma, pancreas cancer and neck department tumour,etc., treat more than 100,000 totally. According to the introduction of the presidents, the third hospital tumour Wang JunJie, directors of rescue center in Peking University of this conference, this treatment is suitable for entity tumour of the diameter under 5 centimetres, is especially suitable for tumour shifting or recuring, and can treat repeatedly many times, can obviously lengthen the patient's life cycle, improve life quality. Because the radiation range of 125I is narrow, scarcely damages the normal organization around tumour. Different from traditional radioactive treatment, this treatment does not need to rely on apparatus of high prices such as the linear accelerator,etc., operation is relatively simple, and the patient treats the low expenses, is suitable for popularizing in most hospitals.


|